Literature DB >> 4986284

Treatment of severe pseudomonas infections of the bronchi.

A Pines, H Raafat, G M Siddiqui, J S Greenfield.   

Abstract

Experience in treating 81 patients with severe bronchial infection with Pseudomonas aeruginosa is described. For those who were desperately ill high doses of intravenous carbenicillin (18g. or more daily) were successful, even when initial carbenicillin resistance was present. For those who were less desperately ill lower doses of carbenicillin together with high doses of gentamicin (given both intramuscularly and by aerosol) comprised the treatment of choice. Gentamicin alone or colistin gave little or no benefit and cannot be recommended.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4986284      PMCID: PMC1700575          DOI: 10.1136/bmj.1.5697.663

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  6 in total

1.  Clinical and laboratory studies with carbenicillin. A new penicillin active against Pseudomonas pyocyanea.

Authors:  W Brumfitt; A Percival; D A Leigh
Journal:  Lancet       Date:  1967-06-17       Impact factor: 79.321

2.  Bacterial precipitins in serum of patients with cystic fibrosis.

Authors:  M W Burns; J R May
Journal:  Lancet       Date:  1968-02-10       Impact factor: 79.321

3.  Carbenicillin: a new semisynthetic penicillin active against Pseudomonas pyocyanea.

Authors:  E T Knudsen; G N Rolinson; R Sutherland
Journal:  Br Med J       Date:  1967-07-08

4.  The treatment of infections due to Pseudomonas aeruginosa with carbenicillin ("Pyopen").

Authors:  B C Stratford
Journal:  Med J Aust       Date:  1968-11-16       Impact factor: 7.738

5.  Pseudomonas infection treated with carbenicillin and gentamicin.

Authors:  R G Cooper; J C Rice; J L Penfold
Journal:  Med J Aust       Date:  1969-03-08       Impact factor: 7.738

6.  Gentamicin and colistin in chronic purulent bronchial infections.

Authors:  A Pines; H Raafat; K Plucinski
Journal:  Br Med J       Date:  1967-05-27
  6 in total
  9 in total

Review 1.  Aerosolised antibacterials for the prevention and treatment of hospital-acquired pneumonia.

Authors:  G Christopher Wood; Joseph M Swanson
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 2.  Infectious diseases: annual review of significant publications.

Authors:  H A Reimann
Journal:  Postgrad Med J       Date:  1971-06       Impact factor: 2.401

3.  Polymyxin Resistance in Klebsiella pneumoniae: Complexity at Every Level.

Authors:  Yohei Doi; David van Duin
Journal:  Clin Infect Dis       Date:  2020-05-06       Impact factor: 9.079

4.  Ventilatory effects of aerosol gentamicin.

Authors:  M B Dally; S Kurrle; A B Breslin
Journal:  Thorax       Date:  1978-02       Impact factor: 9.139

5.  Secondary respiratory infection in hospital patients: effect of antimicrobial agents and environment.

Authors:  J R Philp; R C Spencer
Journal:  Br Med J       Date:  1974-05-18

6.  Specific therapy of Pseudomonas aeruginosa infection.

Authors: 
Journal:  Can Med Assoc J       Date:  1971-11       Impact factor: 8.262

7.  Carbenicillin and gentamicin in the treatment of Pseudomonas aeruginosa infection.

Authors:  K Yuce; C E Van Rooyen
Journal:  Can Med Assoc J       Date:  1971-11       Impact factor: 8.262

Review 8.  Inhaled therapeutics for prevention and treatment of pneumonia.

Authors:  Amar Safdar; Samuel A Shelburne; Scott E Evans; Burton F Dickey
Journal:  Expert Opin Drug Saf       Date:  2009-07       Impact factor: 4.250

9.  Lung transplantation in a patient with fibrosing alveolitis.

Authors:  P Hugh-Jones; A M Macarthur; P A Cullum; S A Mason; W A Crosbie; D C Hutchison; M C Winterton; A P Smith; B Mason; L A Smith
Journal:  Br Med J       Date:  1971-08-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.